Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terazosin Hydrochloride Tablets

Approval Number

国药准字H20083417

Company石家庄科迪药业有限公司

Registration Date

January 18, 2023

Previous Approval Numbers

国药准字H20083417

Drug Information

Generic Name

盐酸特拉唑嗪片

Dosage Form

片剂

Strength

2mg(按C₁₉H₂₅N₅O₄计)

Drug Type

化学药品

Registration Date

January 18, 2023

Company Information

Applicant Company

Company Name石家庄科迪药业有限公司

Company Address

新石北路366号

Manufacturing Company

Company Name石家庄科迪药业有限公司

Company Address

石家庄市新石北路366号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy